Pharmacovigilance, a critical component of drug safety monitoring, involves the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. While pharmacovigilance is essential for all patient populations, special attention must be given to specific groups who may be more vulnerable to adverse drug reactions (ADRs) due to their unique characteristics or underlying health conditions. In this discussion, we will explore pharmacovigilance in special populations concerning the use of anti-tuberculosis drugs, anti-retroviral drugs, and contraceptives.
Many desktop publishing packages and web page editors.
Get notifications and offers as they happen.